top
Search terms
Results 1 - 10 of 153 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 16
Ejhf

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial Research ...

European Journal of Heart Failure, Kristensen, Søren L., Mogensen, Ulrik M., Tarnesby, Georgia, Gimpelewicz, Claudio R., Ali, Mohammed A., Shao, Qing, Chiang, YannTong, Jhund, Pardeep S., Abraham, ...

Date : 01/01/2018 Item size : 167130 bytes
Ejhf

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Aims An excessive production of aldosterone influences outcome ...

European Journal of Heart Failure, Olivier, Arnaud, Pitt, Bertram, Girerd, Nicolas, Lamiral, Zohra, Machu, Jean‐Loup, McMurray, John J.V., Swedberg, Karl, van Veldhuisen, Dirk J., Collier, Timothy ...

Date : 01/09/2017 Item size : 64794 bytes
Ejhf

Despite the availability of a number of different classes of therapeutic agents with proven efficacy in heart failure, the clinical course of heart failure patients is characterized by a reduction in ...

European Journal of Heart Failure, Cowie, Martin R., Filippatos, Gerasimos S., Alonso Garcia, Maria de los Angeles, Anker, Stefan D., Baczynska, Anna, Bloomfield, Daniel M., Borentain, Maria, Bruins ...

Date : 01/06/2017 Item size : 89798 bytes
Ejhf

Objective Plasma concentrations of B-type natriuretic peptide (BNP) and troponin are often measured for diagnostic purposes when patients are admitted with heart failure, but their prognostic value ...

European Journal of Heart Failure, Cleland, John G.F., Teerlink, John R., Davison, Beth A., Shoaib, Ahmad, Metra, Marco, Senger, Stefanie, Milo, Olga, Cotter, Gad, Bourge, Robert C., Parker, John D., ...

Date : 01/06/2017 Item size : 64315 bytes
Ejhf

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia Aims Although hypokalaemia is common among patients with heart failure (HF), the prognostic significance ...

European Journal of Heart Failure, Rossignol, Patrick, Girerd, Nicolas, Bakris, George, Vardeny, Orly, Claggett, Brian, McMurray, John J.V., Swedberg, Karl, Krum, Henry, van Veldhuisen, Dirk J., Shi, ...

Date : 01/06/2017 Item size : 68236 bytes
Ejhf

Noteworthy features of the study include the early enrolment of patients following their initial clinical presentation (within 12 h), and entry blood pressure criteria and thresholds for the ...

European Journal of Heart Failure, Packer, Milton, Holcomb, Richard, Abraham, William T., Anker, Stefan, Dickstein, Kenneth, Filippatos, Gerasimos, Krum, Henry, Maggioni, Aldo P., McMurray, John ...

Date : 01/05/2017 Item size : 66709 bytes
Ejhf

Introduction The angiotensin receptor–neprilysin inhibitor sacubitril/valsartan (formerly known as LCZ696) reduces the risk of both death and hospitalization, compared with an ACE inhibitor, in ...

European Journal of Heart Failure, Cannon, Jane A., Shen, Li, Jhund, Pardeep S., Kristensen, Søren L., Køber, Lars, Chen, Fabian, Gong, Jianjian, Lefkowitz, Martin P., Rouleau, Jean L., Shi, Victor ...

Date : 01/01/2017 Item size : 185519 bytes
Ejhf

Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM‐study ...

European Journal of Heart Failure, Damman, Kevin, Solomon, Scott D., Pfeffer, Marc A., Swedberg, Karl, Yusuf, Salim, Young, James B., Rouleau, Jean L., Granger, Christopher B., McMurray, John J.V.

Date : 01/12/2016 Item size : 183233 bytes
Ejhf

The incremental prognostic and clinical value of multiple novel biomarkers in heart failure Introduction An accurate means of predicting the risk of mortality in heart failure (HF) would allow ...

European Journal of Heart Failure, Jackson, Colette E., Haig, Caroline, Welsh, Paul, Dalzell, Jonathan R., Tsorlalis, Ioannis K., McConnachie, Alex, Preiss, David, Anker, Stefan D., Sattar, Naveed, ...

Date : 01/12/2016 Item size : 160230 bytes
Ejhf

Aims The combined neprilysin/renin–angiotensin system (RAS) inhibitor sacubitril/valsartan reduced cardiovascular death or heart failure hospitalization, cardiovascular death, and all-cause ...

European Journal of Heart Failure, Solomon, Scott D., Claggett, Brian, McMurray, John J.V., Hernandez, Adrian F., Fonarow, Gregg C.

Date : 01/10/2016 Item size : 46771 bytes